☆ 4.5 Article

HSR22-145: Pembrolizumab Plus Chemotherapy for First-Line Treatment of Advanced Triple-Negative Breast Cancer – A Network Meta-Analysis

Journal of the National Comprehensive Cancer Network (2022)

Journal

Journal of the National Comprehensive Cancer Network

Volume 20, Issue 3.5, Pages HSR22-145

Publisher

Harborside Press, LLC

DOI: 10.6004/jnccn.2021.7297

Keywords

-

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.